Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.94
Delayed Data
As of Apr 28
 -0.05 / -0.36%
Today’s Change
7.70
Today|||52-Week Range
15.20
+41.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.8B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Shareholders

Mutual fund holders44.10%
Other institutional27.07%
Individual stakeholders21.83%

Top Executives

There are no executives to display.